PMC:7408073 / 2387-2987 JSONTXT

Annnotations TAB JSON ListView MergeView

    LitCovid-PubTator

    {"project":"LitCovid-PubTator","denotations":[{"id":"98","span":{"begin":7,"end":15},"obj":"Species"},{"id":"99","span":{"begin":65,"end":73},"obj":"Species"},{"id":"100","span":{"begin":430,"end":437},"obj":"Species"},{"id":"101","span":{"begin":470,"end":478},"obj":"Species"},{"id":"127","span":{"begin":56,"end":64},"obj":"Disease"},{"id":"128","span":{"begin":168,"end":174},"obj":"Disease"},{"id":"129","span":{"begin":236,"end":252},"obj":"Disease"},{"id":"130","span":{"begin":282,"end":298},"obj":"Disease"}],"attributes":[{"id":"A98","pred":"tao:has_database_id","subj":"98","obj":"Tax:9606"},{"id":"A99","pred":"tao:has_database_id","subj":"99","obj":"Tax:9606"},{"id":"A100","pred":"tao:has_database_id","subj":"100","obj":"Tax:9606"},{"id":"A101","pred":"tao:has_database_id","subj":"101","obj":"Tax:9606"},{"id":"A127","pred":"tao:has_database_id","subj":"127","obj":"MESH:D004342"},{"id":"A128","pred":"tao:has_database_id","subj":"128","obj":"MESH:D001249"},{"id":"A129","pred":"tao:has_database_id","subj":"129","obj":"MESH:D001102"},{"id":"A130","pred":"tao:has_database_id","subj":"130","obj":"MESH:D004342"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"fected patients in Wuhan [6], but no other asthmatic or allergic patients were described in other reports [1,2,3,4,5,7,8,9], considering that the overall prevalence of asthma is estimated to be 6.4% in Wuhan [6] and ~ 4% in China [10]. Viral infections usually increase the risk of allergic disease exacerbation [1]; however, the reported data seem to suggest that, in this case, the opposite is true. Indeed, in more than 72.000 patient cohorts examined, the number of patients defined as asthmatic was low (5), which suggests that asthmatics might be protected from virus-induced SARS, whereas pre-"}

    LitCovid-PD-MONDO

    {"project":"LitCovid-PD-MONDO","denotations":[{"id":"T26","span":{"begin":56,"end":64},"obj":"Disease"},{"id":"T27","span":{"begin":168,"end":174},"obj":"Disease"},{"id":"T28","span":{"begin":236,"end":252},"obj":"Disease"},{"id":"T29","span":{"begin":282,"end":298},"obj":"Disease"},{"id":"T30","span":{"begin":282,"end":290},"obj":"Disease"},{"id":"T31","span":{"begin":582,"end":586},"obj":"Disease"}],"attributes":[{"id":"A26","pred":"mondo_id","subj":"T26","obj":"http://purl.obolibrary.org/obo/MONDO_0004980"},{"id":"A27","pred":"mondo_id","subj":"T27","obj":"http://purl.obolibrary.org/obo/MONDO_0004979"},{"id":"A28","pred":"mondo_id","subj":"T28","obj":"http://purl.obolibrary.org/obo/MONDO_0005108"},{"id":"A29","pred":"mondo_id","subj":"T29","obj":"http://purl.obolibrary.org/obo/MONDO_0005271"},{"id":"A30","pred":"mondo_id","subj":"T30","obj":"http://purl.obolibrary.org/obo/MONDO_0004980"},{"id":"A31","pred":"mondo_id","subj":"T31","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"}],"text":"fected patients in Wuhan [6], but no other asthmatic or allergic patients were described in other reports [1,2,3,4,5,7,8,9], considering that the overall prevalence of asthma is estimated to be 6.4% in Wuhan [6] and ~ 4% in China [10]. Viral infections usually increase the risk of allergic disease exacerbation [1]; however, the reported data seem to suggest that, in this case, the opposite is true. Indeed, in more than 72.000 patient cohorts examined, the number of patients defined as asthmatic was low (5), which suggests that asthmatics might be protected from virus-induced SARS, whereas pre-"}

    LitCovid-PD-CLO

    {"project":"LitCovid-PD-CLO","denotations":[{"id":"T43843","span":{"begin":568,"end":573},"obj":"http://purl.obolibrary.org/obo/NCBITaxon_10239"}],"text":"fected patients in Wuhan [6], but no other asthmatic or allergic patients were described in other reports [1,2,3,4,5,7,8,9], considering that the overall prevalence of asthma is estimated to be 6.4% in Wuhan [6] and ~ 4% in China [10]. Viral infections usually increase the risk of allergic disease exacerbation [1]; however, the reported data seem to suggest that, in this case, the opposite is true. Indeed, in more than 72.000 patient cohorts examined, the number of patients defined as asthmatic was low (5), which suggests that asthmatics might be protected from virus-induced SARS, whereas pre-"}

    LitCovid-PD-GO-BP

    {"project":"LitCovid-PD-GO-BP","denotations":[{"id":"T87124","span":{"begin":236,"end":252},"obj":"http://purl.obolibrary.org/obo/GO_0016032"}],"text":"fected patients in Wuhan [6], but no other asthmatic or allergic patients were described in other reports [1,2,3,4,5,7,8,9], considering that the overall prevalence of asthma is estimated to be 6.4% in Wuhan [6] and ~ 4% in China [10]. Viral infections usually increase the risk of allergic disease exacerbation [1]; however, the reported data seem to suggest that, in this case, the opposite is true. Indeed, in more than 72.000 patient cohorts examined, the number of patients defined as asthmatic was low (5), which suggests that asthmatics might be protected from virus-induced SARS, whereas pre-"}

    LitCovid-sentences

    {"project":"LitCovid-sentences","denotations":[{"id":"T16","span":{"begin":236,"end":401},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"fected patients in Wuhan [6], but no other asthmatic or allergic patients were described in other reports [1,2,3,4,5,7,8,9], considering that the overall prevalence of asthma is estimated to be 6.4% in Wuhan [6] and ~ 4% in China [10]. Viral infections usually increase the risk of allergic disease exacerbation [1]; however, the reported data seem to suggest that, in this case, the opposite is true. Indeed, in more than 72.000 patient cohorts examined, the number of patients defined as asthmatic was low (5), which suggests that asthmatics might be protected from virus-induced SARS, whereas pre-"}

    LitCovid-PD-HP

    {"project":"LitCovid-PD-HP","denotations":[{"id":"T9","span":{"begin":168,"end":174},"obj":"Phenotype"}],"attributes":[{"id":"A9","pred":"hp_id","subj":"T9","obj":"http://purl.obolibrary.org/obo/HP_0002099"}],"text":"fected patients in Wuhan [6], but no other asthmatic or allergic patients were described in other reports [1,2,3,4,5,7,8,9], considering that the overall prevalence of asthma is estimated to be 6.4% in Wuhan [6] and ~ 4% in China [10]. Viral infections usually increase the risk of allergic disease exacerbation [1]; however, the reported data seem to suggest that, in this case, the opposite is true. Indeed, in more than 72.000 patient cohorts examined, the number of patients defined as asthmatic was low (5), which suggests that asthmatics might be protected from virus-induced SARS, whereas pre-"}

    2_test

    {"project":"2_test","denotations":[{"id":"32708755-32294485-20678634","span":{"begin":26,"end":27},"obj":"32294485"},{"id":"32708755-32077115-20678635","span":{"begin":107,"end":108},"obj":"32077115"},{"id":"32708755-32161940-20678636","span":{"begin":109,"end":110},"obj":"32161940"},{"id":"32708755-32171076-20678637","span":{"begin":111,"end":112},"obj":"32171076"},{"id":"32708755-32109013-20678638","span":{"begin":115,"end":116},"obj":"32109013"},{"id":"32708755-32091533-20678639","span":{"begin":117,"end":118},"obj":"32091533"},{"id":"32708755-31986264-20678640","span":{"begin":119,"end":120},"obj":"31986264"},{"id":"32708755-32297671-20678641","span":{"begin":121,"end":122},"obj":"32297671"},{"id":"32708755-32294485-20678642","span":{"begin":209,"end":210},"obj":"32294485"},{"id":"32708755-31230828-20678643","span":{"begin":231,"end":233},"obj":"31230828"},{"id":"32708755-32077115-20678644","span":{"begin":313,"end":314},"obj":"32077115"}],"text":"fected patients in Wuhan [6], but no other asthmatic or allergic patients were described in other reports [1,2,3,4,5,7,8,9], considering that the overall prevalence of asthma is estimated to be 6.4% in Wuhan [6] and ~ 4% in China [10]. Viral infections usually increase the risk of allergic disease exacerbation [1]; however, the reported data seem to suggest that, in this case, the opposite is true. Indeed, in more than 72.000 patient cohorts examined, the number of patients defined as asthmatic was low (5), which suggests that asthmatics might be protected from virus-induced SARS, whereas pre-"}